Comparative study of the fibrinolytic system in human fetuses and in pregnant women
- PMID: 2028451
- DOI: 10.1016/0049-3848(91)90157-r
Comparative study of the fibrinolytic system in human fetuses and in pregnant women
Abstract
Levels of major parameters of fibrinolysis were measured in 50 normal human fetuses between 19 and 39 weeks of gestation and compared to those of 50 healthy normal pregnant women and 30 adult controls. In fetuses, euglobulin clot lysis time (ECLT) was significantly shortened, plasminogen level was low and histidine-rich glycoprotein undetectable. While t-PA and u-PA levels were slightly lower than in adult controls, a significant decrease in PAI activity was demonstrated and no PAI-2 could be detected in fetal plasma. In contrast with these findings, the fibrinolytic equilibrium of pregnant women exhibited a prolonged ECLT and a strong increase in both PAI activity and PAI-2 antigen levels, while only a moderate elevation in u-PA and t-PA levels was measured.
Similar articles
-
Fibrinolysis during normal human pregnancy: complex inter-relationships between plasma levels of tissue plasminogen activator and inhibitors and the euglobulin clot lysis time.Br J Haematol. 1988 Jun;69(2):253-8. doi: 10.1111/j.1365-2141.1988.tb07630.x. Br J Haematol. 1988. PMID: 3134043
-
Diurnal variation of the fibrinolytic system.Thromb Haemost. 1988 Jun 16;59(3):495-9. Thromb Haemost. 1988. PMID: 3142085
-
Fluctuations of euglobulin lysis time, tissue plasminogen activator, and free and total plasminogen activator inhibitor levels in plasma in daytime.Thromb Res. 1990 Jan 1;57(1):13-20. doi: 10.1016/0049-3848(90)90191-e. Thromb Res. 1990. PMID: 2105539
-
[Progress in the detection of intravascular activation of fibrinolysis].Acta Haematol Pol. 1995;26(1):33-8. Acta Haematol Pol. 1995. PMID: 7747560 Review. Polish.
-
Inhibitors and activators of fibrinolysis during and after childbirth in maternal and cord blood.J Perinat Med. 1989;17(2):113-9. doi: 10.1515/jpme.1989.17.2.113. J Perinat Med. 1989. PMID: 2509671 Review.
Cited by
-
Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Chest. 2012 Feb;141(2 Suppl):e737S-e801S. doi: 10.1378/chest.11-2308. Chest. 2012. PMID: 22315277 Free PMC article.
-
Plasminogen activator inhibitor-2 and impaired fibrinolysis in pregnancy and sickle cell anemia.Arch Gynecol Obstet. 2024 Jun;309(6):2447-2458. doi: 10.1007/s00404-023-07121-6. Epub 2023 Jul 4. Arch Gynecol Obstet. 2024. PMID: 37401942 Free PMC article.
-
Profibrinolytic microparticles are not adequately produced to compensate their prothrombotic effect.Haematologica. 2013 Jul;98(7):e69. doi: 10.3324/haematol.2013.083808. Haematologica. 2013. PMID: 23813649 Free PMC article. No abstract available.
-
Developmental hemostasis in the neonatal period.World J Pediatr. 2022 Jan;18(1):7-15. doi: 10.1007/s12519-021-00492-3. Epub 2022 Jan 4. World J Pediatr. 2022. PMID: 34981411 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous